Biotech News
-
Awakn Responds to OTC Markets Request on Recent Promotional Activity
January 14, 2022 (Source) — Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn”), a biotechnology company…
-
Zentek Announces Binding Letter of Intent with GMAF Circular Medico for ZENGuard(TM)-Enhanced Circular PPE(TM)
January 13, 2022 (Source) — Zentek Ltd. (“ZEN” or the “Company”) (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian IP development and commercialization…
-
XPhyto signs Distribution Agreement for Czech Republic, rollout planned for Hungary, Slovakia, Ukraine and Russia
January 13, 2022 (Source) — XPhyto Therapeutics Corp. (CSE:XPHY)(OTC:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that it…
-
Voyageur Pharmaceuticals Announces IRR of 137% and NPV of $344 Million from Preliminary Economic Assessment for the Frances Creek Pharmaceutical Barium Project
January 11, 2022 (Source) — Voyageur Pharmaceuticals Ltd. (“Voyageur” or the “Company”) (TSXV: VM) is pleased to announce…
-
Hemostemix to Combine ACP-01 with Dr. James Shapiro’s Islet Cells to Treat Type 1 Diabetes
January 11, 2022 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (“Hemostemix” or the “Company”) is pleased…
-
Awakn Life Sciences Announces Positive Results from Phase II A/B Ketamine-Assisted Therapy for Treatment of Alcohol Use Disorder Trial
Primary and Secondary Endpoints Achieved, Including 86% Abstinence Over 6 Months Post Treatment and No Serious Adverse Events…
-
Zentek Announces First Direct Orders Under Its Medical Device Establishment License
January 11, 2022 (Source) — Zentek Ltd. (“ZEN” or the “Company”) (TSX-V:ZEN and OTC:ZENYF), a Canadian IP development and commercialization…
-
XPhyto Announces New Director of Business Development and Head of Diagnostic Research
January 10, 2022 (Source) — XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce two key appointments…
-
Awakn Life Sciences Expands World’s First Ketamine Study Beyond Gambling Disorder to Include Additional Behavioral Addictions
Groundbreaking Psychedelic Study Will Investigate Binge Eating Disorder, Compulsive Sexual Behavior, and Internet Gaming Disorder January 5, 2022…
-
Sixth Wave Issues Shares for Interest
January 5, 2022 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave” or the…
